US Patent Issued to Memorial Sloan-Kettering Cancer Center on Sept. 16 for "Methods and compositions for reducing clostridium difficile infection" (New York, Connecticut Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,969, issued on Sept. 16, was assigned to Memorial Sloan-Kettering Cancer Center (New York).

"Methods and compositions for reducing clostridium difficile infection" was invented by Eric Pamer (Guilford, Conn.), Charlie Buffie (New York) and Peter McKenney (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods and compositions for reducing the risk and severity of C. difficile infection. It is based, at least in part, on the discovery that a restricted fraction of the gut microbiota, including the bacterium Clostridium scindens, contributes substantially to resistance against C. difficile infection. Without ...